Synonyms: Macrogol, PEG, Polyethylene glycol, Polyglycol, Polyethylene oxide, Polyoxy ethylene
CAS: 25322-68-3
| Application | Dosage Form |
|---|---|
| Oral, Parenteral, Rectal, Topical | Capsule, Cream / Gel / Ointment, Injection, Solution, Suppository, Tablet |
Polyethylene Glycol (PEG) has broad applications in liquid, semi-solid and solid dosage forms. Typical functions of high molecular weight PEGs include lubricant and binder for tabletting, or carrier and plasticiser for hot melt extrusion. They are also frequently used for consistency adjustment in creams and ointments, and can easily be blended with low molecular weight PEGs to achieve desired formulation characteristics. Please refer to related articles section below for further available PEG grades.
Solid PEGs are commonly used in pastille or powder form, each with certain benefits for specific processing environments. Both physical forms are available for our solid PEGs.
As certain processes might require elevated temperatures, our PEG articles are optionally also available with a suitable antioxidant to prevent potential degradation.
PEG 4000 is additionally tested for microbiological burden including TAMC/TYMC and bacterial endotoxins and has low Dioxane limits to meet requirements of higher risk applications.
| Article Number | Form | Package Size | Packaging Type |
| 43000112 | Pastilles | 25 kg | PE bag (double layer) |
| 44000010 | Powder | 500 kg | Big bag (PP with PE liner) |
Bottles with smaller quantities, bigbags and custom packaging available on request.
| CAS number | 25322-68-3 |
| INCI | PEG-80 |
| Mol weight (avrg.) | 4000 g/mol |
| Physical form | solid |
| Origin | Synthetic |
| Compendial Compliance | Ph Eur, USP-NF |
| Country of Manufacture | Switzerland |
Kindly Submit the form with your details to continue. Unprotected leaflets will download instantly after submission, while Protected leaflets will be emailed to you personally by the admin.
Please fill in all the required details below to access and download your file instantly.
